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Case of Survival Without Intravenous Nutritional
Support in an Adult with Short Bowel Syndrome
INTRODUCTION
　Short bowel syndrome in adults is defined as 
malabsorption resulting from anatomical or 
functional loss of a significant length of the 
smal intestine. Usualy the length of the 
residual smal intestine is less than 150 cm1).  
Short bowel syndrome in adults can be caused 
by a variety of conditions, most of which are 
the result of vascular or ischemic insults. 
Adults commonly experience short bowel 
syndrome due to trauma, thrombosis, embo-
lism of the mesenteric vessels, inflammatory 
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　We report a case of survival in the absence of intravenous nutritional support in an 
adult patient with short bowel syndrome, despite the very short length of the smal and 
large intestine.
　Short bowel syndrome is defined as malabsorption resulting from anatomical or 
functional loss of the smal intestine. The case is a-59-year- old woman who underwent 
resection of nearly her entire large intestine in response to Gardner Syndrome (familial 
polyposis) about 34 years previously at another hospital. About 30 years ago, at our 
hospital, she underwent a massive intestinal resection because of a mesenteric tumor. 
About 10 years ago, at our hospital, she underwent residual rectum about 12cm due to 
rectal cancer. The length of her residual smal intestine and large intestine was 
ultimately 50cm length and 13cm length, respectively. From our experience, we 
emphasize that there are some cases of short bowel patients who do not require 
intravenous nutritional support and who can maintain themselves on enteral feedings.
Key words : short bowel syndrome, total parenteral nutrition(TPN)
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bowel disease, a volvulus, radiation enteritis, 
or other causes2). Usualy such patients are 
maintained on long-term TPN or, more 
frequently,  are  considered  for  intestinal 
transplantation.
CASE REPORT
　We recently treated a-59-year-old woman 
with a residual smal intestine length of about 
50 cm, who has gone without any intravenous 
nutritional support for nine years. On April 
30,1975, at another hospital her large intestine 
was reduced by about 13 cm in length to treat 
Gardner Syndrome (familial polyposis). On 
February 2, 1979, at our hospital a mesenteric 
tumor was removed and on July 12, 2000, at 
our hospital she was treated for rectal cancer 
(Table 1). She was admitted to our hospital to 
remove a residual rectal polyp on November 
21, 2008. The pathological outcome of the 
polyp was adenoma, a low-grade malignancy, 
and not cancer.
　She  was  diagnosed  with  short  bowel 
syndrome.  Such  patients  usualy  requir 
permanent  parenteral  nutrition  (PN)  to 
maintain their nutritional status. This patient, 
however,  did  not  require  PN  and  was 
discharged wel on December 1, 2008.
　The length of her rectum was about 13 cm, 
due to a partial resection to treat rectal cancer 
on July 12, 2000. After this operation, her 
smal intestine was about 50 cm (not including 
the duodenum) and her large intestine was 
about 13 cm. She did not require intravenous 
nutritional support and she has maintained 
herself on enteral feedings for the nine years 
that have passed since the resection.
　She was 150 cm in height and 49.2 kg in 
body weight on the day of admission, 
　Table 1. The schema of the patients' smal and large intestine, historical changes.
2000.7.12~1981.9.11~ 1979.2.2~
50cm55cm140cmsmal intestine 
13cm25cm25cmlarge intestine
rectal cancerrecurrence of mesentericdisease
mesenteric tumortumor
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November 21, 2008. She underwent surgery to 
remove the polyp on November 26, 2008 and 
she was discharged on November 30, 2008.
　Pre-operative laboratory data were suitable 
to justify discharge: Her T.P. was 7.0g/dl and 
Alb was 4.3 g/dl. She had slight anemia, 
evidenced by an Hb level of 11.9 g/dl and an Ht 
of 35.7%. Post-operative laboratory data were 
favorable as wel (Table 2).
　She was fed rice gruel in our hospital, and 
　Fig. 1. Colonofiber endoscopy of the smal intestinal mucosa inside of the anastomosis.
The mucosa of the smal intestine appeared to be normal. There are some ulcerations on anastomosis 
(arrow).
　Fig. 2. Colonofiber endoscopy of the residual rectal mucosa outside of the anastomosis.
Many polyps were observed on the remaining rectal mucosa.
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she completed each meal oferred to her. Rice 
gruel supplies 1600 kcal per day. The rice gruel 
consisted of 62.5% carbohydrate, 15% protein, 
and 22.5% fat. She defecated from 8 to 14 
times per day. Defecations were nearly al loose 
stools. This was the reason why her condition 
was classified as malabsorptional status. We 
diagnosed the patient with short bowel 
syndrome.
　Colonoscopic results are shown in Figs. 1 
and 2. Roughly one year (November 10, 2009) 
after the removal of the rectal polyp, the 
mucosa of the smal intestine appeared to be 
normal. However, there were many polyps in 
the remaining rectal mucosa (Fig. 2).
DISCUSSION
　Short bowel syndrome in adults is defined as 
malabsorption resulting from anatomical or 
functional loss of a significant length of the 
smal intestine. The usual length of the 
residual smal intestine is less than 150 cm1).  
Enteral nutrition is superior to parenteral 
nutrition for improving nutritional status and 
immune function3). Francisca et al.4) showed 
that continuous tube feeding is useful in cases 
of gastric and smal intestinal motor distur-
bances related to short bowel syndrome, and 
clearly improves intestinal absorption. Recent 
studies have shown that enteral nutrition 
during periods of stress preserve intestinal 
absorption.
　PN is no longer absolutely necessary for the 
survival of short bowel syndrome patients. 
Bernald et al.1) demonstrated that survival of 
these patients was negatively related to 
enterostomy, to a bowel length of less than 50 
cm, and to arterial infarction as a cause for 
bowel resection. Survival was not improved by 
the use of PN.
　Regarding the PN dependence of short 
bowel syndrome patients, Nightingale et al.5) 
observed an intestinal response to food and 
drink if the jejunal length was less than 100 
cm. They emphasized that accurate measure-
ments of the intestinal response to food and 
drink might help to identify those patients who 
require parenteral supplements.
　Wasa et al.6) showed that additional therapeu-
tic agents might be required in adult patients 
with a residual bowel length of less than 50 cm 
in order to alow weaning from TPN. In their 
article, the minimum residual length of the 
smal intestine in adult patients who were 
　Table 2. Laboratory data of the patient
Pre-operative and post-operative laboratory data 
is showed on the table.2. There are no problem  
of these data, especialy their T.P, Alb, transami-
nase, Na, K, Cl et. 
post-operativePre-operative
   6.7   7.0T.P. (g/dl)
   4.0   4.3Alb (g/dl)
 431 438ChE (IU)
  24  21AST (IU) 
  21  20ALT (IU)
 170 171ALP (IU) 
   1.6   0.7T-Bil (mg/dl)
 141 142Na (mEq/l)
   3.7   3.9K (mEq/l)
 105 106Cl (mEq/l)
82606550WBC (103/μl)
 366 366RBC (106/μl)
  11.9  11.9Hb (g/dl)
  35.5  35.7Ht (%)
  38.8   38Plt (103/μl)
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successfuly weaned from TPN was 57 cm. 
These patients had not undergone operations 
on their large intestine. Wilmore et al7) showed 
in their article that 50% of TPN-dependent 
short bowel patients whose length of the smal 
intestine was less than 50cm, could be weaned 
of the TPN if their large intestine  remained 
intact7).
　The woman reported in our case has 
maintained self-administered enteral feeding. 
This is extremely rare in cases of short bowel 
syndrome. Our patient had undergone surgery 
on her large intestine due to Gardner 
Syndrome about 34 years previously. At that 
time, the residual length of her smal intestine 
was about 140 cm and the residual length of 
her large intestine was about 25 cm. Later, on 
September 11 1981, she underwent smal 
intestine resection due to the recurrence of a 
mesenteric tumor. On July 7, 2000, her 
residual rectum was resected by about 12 cm 
due to rectal cancer, which pathological 
examination determined to be a submucosal 
invasion of adenocarcinoma. After this opera-
tion, the length of her residual smal intestine 
was about 50 cm and the length of her residual 
large intestine was about 13 cm (Table 1).
　Her ability to maintain her nutritional 
status solely through enteral feeding, without 
PN support, was due to the fact that her 
digestion and absorption abilities were similar 
to those of normal patients. We speculate that 
her residual smal intestine had compensated 
for the loss of bowel length during the 30 years 
since  the  resection  surgery.  With  bowel 
compensation,absorption of enteral nutrients 
is gradualy enhanced, while diarrhea and 
malabsorption decrease8). Byrne et al.8) showed 
that a high-carbohydrate, low-fat diet, admini-
stration of the amino acid glutamine, and the 
administration of growth hormone reduced 
TPN requirements for short bowel patients8). 
By using these combined therapies, the 
researchers showed that 40% of TPN-depend-
ent short bowel patients could be weaned from 
TPN, and that an additional 40% showed a 
reduction in their TPN requirements. Mutoh 
et al9) showed in their article that the overal 
prevalence of hyperlipidemia in FAP cases was 
58%. This might be one of the reasons why our 
case was able to survive without requiring 
intravenous nutritional support, although the 
lengths of her smal and large intestine were 
very short.
　It is possible that our patient had consumed 
a high-carbohydrate, low-fat diet for these past 
30 years.
　From our experience, we emphasize that 
there are some cases of short bowel patients 
who do not require intravenous nutritional 
support and who are able to maintain 
themselves on enteral feedings. Therefore, we 
should tend carefuly to these short bowel 
patients as they may be able to wean of TPN 
in the future.
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